From latent to patent: rethinking prediction of tuberculosis. (2017)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(16)30419-2
PubMed Identifier: 28017341
Publication URI: http://europepmc.org/abstract/MED/28017341
Type: Journal Article/Review
Volume: 5
Parent Publication: The Lancet. Respiratory medicine
Issue: 4
ISSN: 2213-2600